Characterization/NN
of/IN
interleukin-10/NN
receptor/NN
expression/NN
on/IN
B-cell/NN
chronic/JJ
lymphocytic/JJ
leukemia/NN
cells/NNS
./.

B-cell/NN
chronic/JJ
lymphocytic/JJ
leukemia/NN
(/(
B-CLL/NN
)/)
cells/NNS
accumulate/VBP
in/FW
vivo/FW
in/IN
the/DT
G0/G1/NN
phase/NN
of/IN
the/DT
cell/NN
cycle/NN
,/,
suggesting/VBG
that/IN
their/PRP$
malignant/JJ
expansion/NN
is/VBZ
due/JJ
,/,
at/IN
least/JJS
in/IN
part/NN
,/,
to/TO
a/DT
delay/NN
in/IN
cell/NN
death/NN
./.
=====
However/RB
,/,
the/DT
cellular/JJ
or/CC
molecular/JJ
factors/NNS
responsible/JJ
for/IN
a/DT
delay/NN
in/IN
B-CLL/NN
cell/NN
death/NN
are/VBP
unknown/JJ
./.
=====
B-CLL/NN
cells/NNS
do/VBP
express/VB
receptors/NNS
for/IN
interferon-alpha/NN
(/(
IFN-alpha/NN
)/)
and/CC
IFN-gamma/NN
,/,
and/CC
activation/NN
of/IN
both/DT
has/VBZ
been/VBN
shown/VBN
to/TO
promote/VB
B-CLL/NN
survival/NN
in/FW
vitro/FW
by/IN
preventing/VBG
apoptosis/NN
./.
=====
The/DT
interleukin-10/NN
(/(
IL-10/NN
)/)
receptor/NN
is/VBZ
another/DT
member/NN
of/IN
the/DT
IFN/NN
receptor/NN
family/NN
,/,
but/CC
its/PRP$
ligand/NN
,/,
IL-10/NN
,/,
has/VBZ
been/VBN
reported/VBN
to/TO
induce/VB
apoptosis/NN
in/IN
B-CLL/NN
cells/NNS
./.
=====
In/IN
the/DT
current/JJ
study/NN
,/,
we/PRP
undertook/VBD
a/DT
biochemical/JJ
analysis/NN
of/IN
IL-10/NN
receptor/NN
expression/NN
on/IN
freshly/RB
isolated/VBN
B-CLL/NN
cells/NNS
and/CC
characterized/VBD
the/DT
functional/JJ
responsiveness/NN
of/IN
IL-10/NN
binding/NN
to/TO
its/PRP$
constitutively/RB
expressed/VBN
receptor/NN
./.
=====
We/PRP
show/VBP
that/IN
B-CLL/NN
cells/NNS
bind/VBP
IL-10/NN
with/IN
significant/JJ
specificity/NN
and/CC
express/VBP
between/IN
47/CD
and/CC
127/CD
IL-10/NN
receptor/NN
sites/NNS
per/IN
cell/NN
,/,
with/IN
a/DT
dissociation/NN
constant/NN
in/IN
the/DT
range/NN
of/IN
168/CD
to/TO
426/CD
x/CC
10(-12)/CD
mol/L/NN
./.
=====
Ligand/NN
binding/NN
and/CC
activation/NN
of/IN
the/DT
IL-10/NN
receptor/NN
expressed/VBN
on/IN
B-CLL/NN
cells/NNS
results/VBZ
in/IN
the/DT
phosphorylation/NN
of/IN
signal/NN
transducer/NN
and/CC
activator/NN
of/IN
transcription/NN
1/CD
(/(
STAT1/NN
)/)
and/CC
STAT3/NN
proteins/NNS
./.
=====
This/DT
pattern/NN
of/IN
STAT/NN
protein/NN
phosphorylation/NN
is/VBZ
identical/JJ
to/TO
IL-10/NN
receptor/NN
activation/NN
on/IN
normal/JJ
cells/NNS
and/CC
similar/JJ
to/TO
IFN-alpha/NN
(/(
STAT1/NN
and/CC
STAT3/NN
)/)
and/CC
IFN-gamma/NN
(/(
STAT1/NN
)/)
receptor/NN
activation/NN
in/IN
CLL/NN
./.
=====
Further/RB
,/,
in/IN
consecutive/JJ
samples/NNS
of/IN
fresh/JJ
blood/NN
obtained/VBN
from/IN
patients/NNS
with/IN
B-CLL/NN
cells/NNS
,/,
the/DT
addition/NN
of/IN
IL-10/NN
inhibited/VBD
B-CLL/NN
proliferation/NN
,/,
enhanced/VBD
B-CLL/NN
differentiation/NN
,/,
but/CC
did/VBD
not/RB
induce/VB
apoptosis/NN
./.
=====
Indeed/RB
,/,
IL-10/NN
,/,
like/IN
IFN-gamma/NN
,/,
was/VBD
able/JJ
to/TO
significantly/RB
reduce/VB
the/DT
amount/NN
of/IN
B-CLL/NN
cell/NN
death/NN
caused/VBN
by/IN
hydrocortisone-induced/JJ
apoptosis/NN
./.
=====
We/PRP
conclude/VBP
that/IN
cytokines/NNS
,/,
which/WDT
signal/VBP
through/IN
the/DT
interferon/NN
family/NN
of/IN
receptors/NNS
,/,
have/VBP
comparable/JJ
functional/JJ
effects/NNS
on/IN
B-CLL/NN
cells/NNS
./.